GridAI Technologies (GRDX) Accumulated Expenses (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Accumulated Expenses came in at $1.4 million in Q4 2025, up 469.27% YoY from $252048.0 in Q4 2024, and up 249.68% on a QoQ basis from $410324.0 in Q3 2025.
GridAI Technologies (GRDX) Accumulated Expenses (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Accumulated Expenses data on file, last reported at $1.4 million in Q4 2025.
- Quarterly Accumulated Expenses rose 469.27% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (up 469.27% YoY) and the FY2025 annual result came in at $1.4 million, up 469.27% from the prior year.
- Accumulated Expenses grew to $1.4 million in Q4 2025, from $410324.0 in the prior quarter.
- In the past five years, Accumulated Expenses ranged from a high of $1.8 million in Q2 2024 to a low of $7351.0 in Q3 2023.
- A 5-year average of $464724.5 and a median of $320176.0 in 2022 frame the typical range for Accumulated Expenses.
- The widest YoY moves for Accumulated Expenses: up 4765.54% in 2023, down 97.3% in 2023.
- Tracing GRDX's Accumulated Expenses over 5 years: stood at $393253.0 in 2021, then fell by 18.58% to $320176.0 in 2022, then soared by 157.76% to $825290.0 in 2023, then slumped by 69.46% to $252048.0 in 2024, then surged by 469.27% to $1.4 million in 2025.
- The last three Accumulated Expenses figures came in at $1.4 million (Q4 2025), $410324.0 (Q3 2025), and $415444.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | GridAI Technologies | 5.82 Mn | 5.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.43 Mn |
| Sep 30, 2025 | 410,324.00 |
| Jun 30, 2025 | 415,444.00 |
| Mar 31, 2025 | 303,880.00 |
| Dec 31, 2024 | 252,048.00 |
| Sep 30, 2024 | 219,193.00 |
| Jun 30, 2024 | 1.82 Mn |
| Mar 31, 2024 | 54,986.00 |
| Dec 31, 2023 | 825,290.00 |
| Sep 30, 2023 | 7,351.00 |
| Jun 30, 2023 | 479,862.00 |
| Mar 31, 2023 | 845,728.00 |
| Dec 31, 2022 | 320,176.00 |
| Sep 30, 2022 | 272,268.00 |
| Jun 30, 2022 | 426,235.00 |
| Mar 31, 2022 | 17,382.00 |
| Dec 31, 2021 | 393,253.00 |
| Sep 30, 2021 | 135,072.00 |
| Jun 30, 2021 | 193,975.00 |
| Dec 31, 2020 | 127,012.00 |